Telangiectasis: Clinical Trials

9 trials for Telangiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 9

Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brimonidine 0.33% for Rosacea-Related Facial Erythema
Brimonidine 0.33% gel, Placebo gel - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Phase 4CompletedIstanbul Training and Research Hospital452025-05-012026-02-24
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
The Vbeam® Prima System, Oxymetazoline HCL 1% Cream - Erythematotelangiectatic Rosacea
Phase 4CompletedCandela Corporation342019-01-152022-03-31
NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial
Doxycycline, Placebo - Epistaxis
Phase 4CompletedUniversity of California, Los Angeles262017-12-182022-07-20
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Metformin, Pioglitazone - Ataxia-Telangiectasia
Phase 4CompletedNHS Tayside272016-09-292017-12-04
Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
Brimonidine, IPL+air-cooling - Telangiectasias
Phase 4CompletedMerete Haedersdal192016-03-132018-01-05
Polidocanol Versus Glucose Treatment of Telangiectasia Trial
Glucose, Polidocanol with Glucose - Varicose Veins, Telangiectasis
Phase 4CompletedUPECLIN HC FM Botucatu Unesp1152015-01-012018-01-04
Intranasal Bevacizumab for HHT-Related Epistaxis
Bevacizumab, Placebo (Saline) - HHT, Hereditary Hemorrhagic Telangiectasia
Phase 4CompletedStanford University402014-08-042021-09-01
Treatment of Lower Extremity Spider Veins With Excel V
532 nm KTP Excel V Laser, manufactured by Cutera, Inc. - Telangiectasis, Spider Veins
Phase 4CompletedCutera Inc.202011-05-012015-01-29
Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias
Bipolar eletrocoagulation, Argon Plasma Coagulation - Radiation Injuries, Telangiectasis
Phase 4CompletedFederal University of São Paulo302005-05-012008-10-17

Narrower conditions

Epistaxis (2)  ·  Rosacea (2)  ·  Telangiectasia, Hereditary Hemorrhagic (2)  ·  Ataxia Telangiectasia (1)  ·  Depression (1)  ·  Erythema (1)  ·  Inflammation (1)  ·  Radiation Injuries (1)  ·  Varicose Veins (1)

Broader conditions

Cardiovascular Diseases (9)  ·  Vascular Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Pathologic Processes (3)  ·  Signs and Symptoms (3)  ·  Cardiovascular Abnormalities (2)  ·  Congenital Abnormalities (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhage (2)  ·  Hemorrhagic Disorders (2)  ·  Hemostatic Disorders (2)  ·  Nose Diseases (2)

Interventions

Brimonidine Tartrate (2)  ·  Argon Plasma Coagulation (1)  ·  Bevacizumab (1)  ·  Doxycycline (1)  ·  Fluoridation (1)  ·  Gels (1)  ·  Glucose (1)  ·  Lasers, Gas (1)  ·  Metformin (1)  ·  Oxymetazoline (1)  ·  Pioglitazone (1)  ·  Polidocanol (1)  ·  Sodium Chloride (1)

Sponsors

Candela Corporation (1)  ·  Cutera Inc. (1)  ·  Federal University of São Paulo (1)  ·  Istanbul Training and Research Hospital (1)  ·  Merete Haedersdal (1)  ·  NHS Tayside (1)  ·  Stanford University (1)  ·  UPECLIN HC FM Botucatu Unesp (1)  ·  University of California, Los Angeles (1)

Countries

United States (4)  ·  Brazil (2)  ·  Denmark (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Angelo Ferrari, PhD (1)  ·  Ewan Pearson, MD PhD (1)  ·  Konika P Schallen, MD (1)  ·  Matheus Bertanha, Dr (1)  ·  Peter H Hwang, MD (1)

Results publications

PMID 23839181, PMID 27684809, PMID 34233378

NIH funding

2015 (1)